Correlates of the spread of human papillomavirus infection - PubMed (original) (raw)
Affiliations
- PMID: 11008914
Correlates of the spread of human papillomavirus infection
I Silins et al. Cancer Epidemiol Biomarkers Prev. 2000 Sep.
Abstract
Knowledge of the correlates of human papillomavirus (HPV) seropositivity is of interest for planning of preventive measures and for evaluation of possible confounding in epidemiological studies. The epidemiological determinants for seropositivity for oncogenic and benign HPV types were assessed using a serosurvey of 275 healthy Swedish women, stratified by age and lifetime number of sexual partners. Seroprevalences were compared with 17 behavioral variables obtained by interview and 3 laboratory-diagnosed microbiological exposures. In univariate analysis, history of gonorrhea and condylomatosis, human herpesvirus type 8 and herpes simplex virus 2 seropositivities, lifetime number of sexual partners, and current partner's lifetime number of sexual partners were associated with oncogenic HPV seropositivity. Noteworthy lack of correlations included smoking habits and oral contraceptive use. In multivariate analysis, only the number of lifetime sexual partners [odds ratio (OR), 8.7; 95% confidence interval (CI), 3.3-22.6] and seropositivity for benign HPV types remained significant (OR, 2.9; 95% CI, 1.6-5.3). Seropositivity for benign HPV was primarily associated with condyloma history (OR, 3.6; 95% CI, 1.2-10.8) and seropositivity for oncogenic HPV (OR, 2.9; 95% CI, 1.6-5.2). An association with sexual history lost significance in the multivariate model. In conclusion, lifetime number of sexual partners is the major determinant of acquisition of oncogenic HPV. By contrast, benign HPV infection associates more strongly with condyloma history than with sexual history per se.
Similar articles
- Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJ, Clifford GM, Smith JS, Lazcano-Ponce E, Sukvirach S, Shin HR, de Sanjosé S, Molano M, Matos E, Ferreccio C, Anh PT, Thomas JO, Meijer CJ; IARC HPV Prevalence Surveys Study Group. Vaccarella S, et al. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):326-33. doi: 10.1158/1055-9965.EPI-05-0577. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492924 - Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
Hildesheim A, Han CL, Brinton LA, Kurman RJ, Schiller JT. Hildesheim A, et al. Obstet Gynecol. 1997 Nov;90(5):748-54. doi: 10.1016/S0029-7844(97)00467-5. Obstet Gynecol. 1997. PMID: 9351758 - Human papillomavirus infection and its relationship to recent and distant sexual partners.
Fairley CK, Chen S, Ugoni A, Tabrizi SN, Forbes A, Garland SM. Fairley CK, et al. Obstet Gynecol. 1994 Nov;84(5):755-9. Obstet Gynecol. 1994. PMID: 7936507 - High risk genital papillomavirus infections are not spread vertically.
Dillner J, Andersson-Ellström A, Hagmar B, Schiller J. Dillner J, et al. Rev Med Virol. 1999 Jan-Mar;9(1):23-9. doi: 10.1002/(sici)1099-1654(199901/03)9:1<23::aid-rmv233>3.0.co;2-s. Rev Med Virol. 1999. PMID: 10371669 Review. - Epidemiology of cervical human papillomavirus infections.
Schiffman MH. Schiffman MH. Curr Top Microbiol Immunol. 1994;186:55-81. doi: 10.1007/978-3-642-78487-3_4. Curr Top Microbiol Immunol. 1994. PMID: 8205846 Review. No abstract available.
Cited by
- Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer.
Läsche M, Gallwas J, Gründker C. Läsche M, et al. Int J Mol Sci. 2022 May 2;23(9):5050. doi: 10.3390/ijms23095050. Int J Mol Sci. 2022. PMID: 35563441 Free PMC article. Review. - The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers.
James CD, Morgan IM, Bristol ML. James CD, et al. Pathogens. 2020 May 22;9(5):403. doi: 10.3390/pathogens9050403. Pathogens. 2020. PMID: 32455952 Free PMC article. Review. - Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile.
Castro FA, Dominguez A, Puschel K, Van De Wyngard V, Snijders PJ, Franceschi S, Pawlita M, Ferreccio C. Castro FA, et al. BMC Infect Dis. 2014 Jul 3;14:361. doi: 10.1186/1471-2334-14-361. BMC Infect Dis. 2014. PMID: 24990706 Free PMC article. - Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.
Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, van Doorn LJ, Herrero R, Pinto LA, Hildesheim A, Waterboer T, Safaeian M. Robbins HA, et al. BMC Infect Dis. 2014 Mar 3;14:120. doi: 10.1186/1471-2334-14-120. BMC Infect Dis. 2014. PMID: 24588945 Free PMC article. - DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.
Ermel AC, Shew ML, Weaver BA, Qadadri B, Denski C, Tu W, Tong Y, Fortenberry JD, Brown DR. Ermel AC, et al. Sex Transm Infect. 2014 Feb;90(1):64-9. doi: 10.1136/sextrans-2012-050886. Epub 2013 Sep 12. Sex Transm Infect. 2014. PMID: 24031030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical